Regent Pacific Group Limited Stock Deutsche Boerse AG

Equities

RPG

KYG3042R1314

Pharmaceuticals

Market Closed - Deutsche Boerse AG 02:20:01 2024-05-31 EDT 5-day change 1st Jan Change
0.06 EUR -4.00% Intraday chart for Regent Pacific Group Limited +12.15% -1.64%

Financials

Sales 2022 35K 32.27K 47.69K Sales 2023 291K 268K 397K Capitalization 18.13M 16.72M 24.71M
Net income 2022 -36M -33.2M -49.05M Net income 2023 -25M -23.05M -34.06M EV / Sales 2022 1,045 x
Net Debt 2022 12.29M 11.33M 16.75M Net cash position 2023 1.22M 1.12M 1.66M EV / Sales 2023 58.1 x
P/E ratio 2022
-0.67 x
P/E ratio 2023
-0.71 x
Employees 17
Yield 2022 *
-
Yield 2023
-
Free-Float 40.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.00%
1 week+12.15%
1 month+66.67%
3 months+37.93%
6 months-17.81%
Current year-1.64%
More quotes
1 week
0.06
Extreme 0.06
0.07
1 month
0.03
Extreme 0.03
0.07
Current year
0.02
Extreme 0.02
0.07
1 year
0.02
Extreme 0.02
0.13
3 years
0.02
Extreme 0.02
0.43
5 years
0.02
Extreme 0.02
0.63
10 years
0.02
Extreme 0.02
1.86
More quotes
Date Price Change
24-05-31 0.06 -4.00%
24-05-30 0.0625 -3.85%
24-05-29 0.065 +5.69%
24-05-28 0.0615 +1.65%
24-05-27 0.0605 +13.08%

Delayed Quote Deutsche Boerse AG, May 31, 2024 at 02:20 am

More quotes
Regent Pacific Group Ltd, formerly Endurance RP Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. It offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.
More about the company